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Abstract Sir2 is an NAD-dependent histone deacetylase that
functions in longevity, gene silencing, heterochromatin forma-
tion, DNA repair, and suppression of DNA recombination in
yeast. The mammalian homolog Sir2K (SIRT1) has been shown
to inhibit p53-dependent apoptosis, but its physiological roles
are still not known. We found that the level of Sir2K expression
during embryogenesis was high. The highest Sir2K mRNA ex-
pression was detected as early as embryonic day (E) 4.5.
Although the level was down-regulated during embryogenesis,
a high level of expression was still found in the late embryonic
stage (E18.5). In embryos, Sir2K was expressed at high levels in
the heart, brain, spinal cord, and dorsal root ganglia. The ex-
pression levels in these organs were high on E10.5^E13.5 and
low on E16.5. Quantitative reverse transcription polymerase
chain reaction showed a 60% reduction in Sir2K mRNA content
in the heart between E12.5 and E14.5. After E14.5, the expres-
sion level in the heart remained constant up to 27 months of age.
The expression pattern of Sir2K protein in embryonic hearts
was consistent with that of mRNA. These results suggest new
roles of Sir2K not only in early embryogenesis but also in car-
diogenesis and neurogenesis with a stage-speci¢c manner.
3 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The silent information regulator 2 (Sir2) has been shown to
be an essential component for silencing of yeast silent mating
type loci [1]. In yeast, Sir2 functions in gene silencing, hetero-
chromatin formation, DNA repair, and suppression of DNA
recombination [2^4]. Sir2 is a nicotinamide adenine dinucleo-
tide (NAD)-dependent histone deacetylase and has been
shown to deacetylate histone H3 and H4 in the presence of
NAD [5]. Overexpression of Sir2 induces longevity of yeasts
[6] and Caenorhabditis elegans [7]. Calorie restriction extends
the lifespans of a broad range of organisms, from yeasts to
mammals [8,9]. Sir2 is necessary for extension of yeast lifespan
by calorie restriction [10]. Sir2 is evolutionarily conserved
from bacteria to humans. Seven human Sir2 homologs, named
SIRT1^7, have so far been identi¢ed [11,12]. SIRT1, 2, and 3
have NAD-dependent protein deacetylase activities. SIRT2
colocalizes with microtubules and deacetylates tubulin [13].
SIRT3 is a mitochondrial NAD-dependent deacetylase that
is located in the mitochondrial matrix [14]. Sir2K (SIRT1) is
a nuclear protein that has been shown to deacetylate not only
histone but also the tumor suppressor p53 [15,16]. Sir2K di-
rectly binds to p53 and suppresses p53-dependent apoptosis in
response to DNA damage. It has been reported that the £y
Sir2 ortholog a¡ects segmentation and sex determination [17]
and that developmental defects in the brain [18], heart [18,19],
and retina [19] were observed in Sir2K-null mice. These studies
suggest that Sir2K is important in embryonal development.
Although it has been shown that two-cell embryos express
Sir2K [18], little is known about the expression of Sir2K in
the embryo.
In this study, we investigated the expression of Sir2K in
mouse embryos to try to obtain an insight into the function
of Sir2K in the developmental process. We unexpectedly found
that Sir2K is expressed at high levels in mouse embryos. Sir2K
was found to be widely expressed in embryonic organs, and its
expression levels in the heart and brain were high in speci¢c
embryonic stages, suggesting that Sir2K has an as yet unde-
termined role in embryonic development.
2. Materials and methods
This study conformed to the Guide for the Care and Use of Lab-
oratory Animals published by the US National Institutes of Health
(NIH publication no. 85-23, revised 1996) and to the Guideline for
Animal Experiments in Sapporo Medical University.
2.1. cDNA cloning of Sir2K
A lambda zap mouse brain cDNA library (Stratagene) was screened
using a mouse Sir2K (SIRT1) cDNA fragment corresponding to nu-
cleotides 968^1261 in the coding region of mouse Sir2K cDNA
(AF214646). The cDNA fragment was obtained by reverse transcrip-
tion polymerase chain reaction (RT-PCR) of mouse brain total RNA
using a primer set of 5P-AATATATCCCGGACAGTTC-3P and 5P-
AAGACAATCTCTGGCTTCA-3P. For the expression of Sir2K
cDNA, the coding region of mouse Sir2K cDNA was subcloned in
pIRES-hrGFP-1a (Stratagene).
2.2. Tissue distribution of the Sir2K mRNA and quantitative RT-PCR
For tissue distribution analysis, total RNA was puri¢ed from var-
ious normal mouse tissues using an RNeasy Mini kit (Qiagen). RT-
PCR was performed using Ready-To-Go RT-PCR beads (Amersham
Pharmacia Biotech). The primer sets used were 5P-CCCCATGAAG-
TGCCTCAAAT-3P and 5P-GATTACCCTCAAGCCGCTTA-3P, cor-
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responding to nucleotide positions 1342^1361 and 1872^1891, respec-
tively, in the Sir2K cDNA and the expected size of the PCR product is
550 bp. The cDNA clones were used as a positive control and a
negative control was done in which the ¢rst step of reverse transcrip-
tion was omitted in the RT-PCR. The conditions for PCR ampli¢ca-
tions were: denaturation at 95‡C for 30 s; annealing at 55‡C for 30 s,
and then elongation at 72‡C for 1 min. The ampli¢ed products were
analyzed on a 2% agarose gel and visualized by staining with ethidium
bromide.
Real-time quantitative RT-PCR was performed using an ABI Prism
7700 sequence detection system and TaqMan One-Step RT-PCR
Master Mix Reagents (ABI). Primers for the Sir2K mRNA were de-
signed using Primer Express software (ABI), and the Sir2K primer
sequences used were 5P-TCCTCACTAATGGCTTTCATTCCT-3P
and 5P-CGCGGAGTCCAGTCACTAGAG-3P. The probe sequence
was FAM-ATGACGATGACAGAACGTCACACGCC-TAMRA.
The conditions of one-step RT-PCR were as follows: 30 min at
48‡C, 10 min at 95‡C, and then 45 cycles of ampli¢cation for 15 s
at 95‡C, 60 s at 55‡C and 30 s at 72‡C. Commercially available
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers and a
probe (TaqMan Rodent GAPDH Control Reagent, ABI) were used
to quantify GAPDH for standardization of the reaction. The expres-
sion levels of Sir2K mRNA were normalized by the contents of
GAPDH mRNAs.
2.3. Preparation of anti-Sir2K polyclonal antibody
The polyclonal antibody for mouse Sir2K was raised in a rabbit
against a synthetic peptide corresponding to amino acid residues
722^737 (ATRQELTDVNYPSDKS) in the C-terminal region of
mouse Sir2K. The antiserum was puri¢ed with antigenic peptide-
coupled Sulfolink resin (Pierce).
2.4. Western blot analysis
COS7 cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% fetal bovine serum with 5% CO2 at 37‡C.
Cells plated in six-well culture dishes were transfected with a
pIRES-hrGFP-1a vector containing Sir2K cDNA or an empty vector
using LipofectAMINE2000 (Life Technologies) following the manu-
facturer’s instructions. Forty-eight hours after transfection, cells were
lysed in a lysis bu¡er (50 mM Tris^HCl, pH 7.4, 150 mM NaCl, 5 mM
EDTA and 0.1% (w/v) sodium dodecyl sulfate (SDS)) and vortexed
vigorously. The debris in cell lysates was removed by centrifugation.
Lysates were analyzed in 7.5% SDS^polyacrylamide gels and electro-
blotted onto polyvinylidene di£uoride (PVDF) membranes (Milli-
pore). The membranes were probed with an anti-Sir2K antibody
and incubated with an horseradish peroxidase-conjugated antibody
against rabbit IgG (Santa Cruz). For a control experiment, an anti-
Sir2K antibody preabsorbed with excess antigenic peptide was used.
To investigate the developmental changes in the amount of Sir2K in
the heart, embryos of ddY mice were soaked in phosphate-bu¡ered
saline, and embryonic hearts at embryonic day (E) 12.5, E14.5 and
E16.5 were dissected. Hearts were also obtained from 1-day-old, 10-
week-old and 27-month-old ddY mice. Hearts were homogenized in a
lysis bu¡er and lysates were transferred onto PVDF membranes as
described above, and the membranes were incubated with an anti-
Sir2K antibody. As a protein loading control, membranes were also
incubated with anti-GAPDH antibody (Chemicon). Immunoreactive
bands were visualized by SuperSignal enhanced chemiluminescence
(Pierce) using the luminescent image analysis system LAS-1000 (Fuji-
¢lm).
2.5. Fluorescent immunostaining
COS7 cells transfected with Sir2K cDNA or the control vector were
¢xed in 4% paraformaldehyde and 0.1 M sodium phosphate, pH 7.4,
48 h after transfection and permeabilized with 0.1% Triton X-100 for
10 min at room temperature. The cells were incubated with anti-Sir2K
antibody (1:500 dilution) for 30 min at room temperature and then
with Alexa Fluor 594-conjugated goat anti-rabbit secondary antibody
(Molecular Probes). For a control experiment, Sir2K antibody prein-
cubated with an excess of peptide was used. The cell nucleus was
stained with 1 Wg/ml Hoechst 33342 dye (Sigma). Stained cells were
examined using a laser scanning confocal £uorescent microscope (Ra-
diance 2100, Bio-Rad).
2.6. Immunohistochemistry of mouse embryos
Timed pregnant ddY mice were obtained from Sankyo Labo Ser-
vice. Mice were deeply anesthetized and killed at various gestation
stages. Embryos were dissected from extra-embryonic membranes,
washed in phosphate-bu¡ered saline, embedded in the Tissue-Tek
OCT compound (Sakura Finetechnical), and immediately frozen.
Samples were kept at 380‡C until use. Sagittal cryostat sections
were cut (5 Wm) and collected on MAS-coated slides (Matsunami).
Sections were ¢xed for 7 min in methanol:acetone (1:1) at 320‡C,
incubated with 3% H2O2 for 30 min to block endogenous peroxidase
activity, treated with 5% normal goat serum, and then incubated over-
night with Sir2K antibody (1:500 dilution) at 4‡C. Immunodetection
was carried out using a biotinylated goat anti-rabbit antiserum and a
Vectastain ABC kit (Vector Laboratories). Sections were photo-
graphed on an Olympus SZX9 dissection microscope or a Nikon
Eclipse E600 microscope.
2.7. Quantitation of Sir2K mRNA in the mouse heart at di¡erent stages
Mouse hearts at various ages were collected for measurements of
Sir2K mRNA levels. Isolated hearts were £ash-frozen in liquid nitro-
gen and stored at 380‡C until RNA puri¢cation. Total RNA was
isolated using an RNeasy Mini kit (Qiagen). Quantitative RT-PCR
was carried out as described above to determine Sir2K mRNA levels
in the heart. The expression levels of Sir2K mRNA were normalized
by the contents of GAPDH mRNAs and mean Sir2K mRNA levels
were compared between groups by analysis of variance followed by a
post-hoc multiple comparison test. A P value 6 0.05 was considered
statistically signi¢cant.
3. Results
3.1. Sir2K cDNA cloning
We cloned mouse Sir2K cDNA from a mouse brain cDNA
library. One full-size Sir2K cDNA clone (3.9 kb) was isolated
from 6U105 phage clones. The nucleotide sequence and de-
duced amino acid sequence were identical to those previously
reported [5].
3.2. Expression of Sir2K mRNA in adult mouse tissues
The tissue distribution of Sir2K mRNA was examined by
RT-PCR. As illustrated in Fig. 1A, we detected the expression
of Sir2K transcript in all tissues examined. The expression
levels of Sir2K mRNA in various tissues were determined by
quantitative RT-PCR (Fig. 1B). Sir2K mRNA levels were
normalized to the contents of GAPDH mRNA. The quantity
varied considerable among the tissues and the highest expres-
sion was detected in the lung followed by the testis. Moderate
levels of expression were observed in the ovary, spleen, thy-
mus, heart, and E14.5 embryos.
3.3. Developmental changes in Sir2K mRNA expression
It has been demonstrated that the £y Sir2 ortholog a¡ects
segmentation and sex determination [17] and that Sir2K-null
mice exhibit developmental defects [18,19]. It has also been
reported that two-cell-stage embryos expressed high levels of
Sir2K [18]. These results prompted us to examine the expres-
sion pro¢le of Sir2K mRNA during embryogenesis. Total
RNAs of mouse whole embryos from E4.5 to E18.5 were
analyzed by Northern blotting. As shown in Fig. 1C, embryos
expressed abundant amounts of Sir2K mRNA. The highest
expression levels were found in early-stage embryos. The ex-
pression levels of Sir2K mRNA continuously decreased with
progression of embryonic development, but, unexpectedly, a
high expression level of Sir2K mRNA persisted until late de-
velopmental stages. Densitometric analysis of blots normal-
ized by S28 ribosomal RNA intensity showed that the expres-
sion level of Sir2K mRNA on E18.5 had decreased by 60%
compared with that on E4.5 (Fig. 1D). Thus, we found that
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Sir2K mRNA is expressed in a highly stage-speci¢c manner in
the embryo.
3.4. Characterization of a polyclonal antibody and expression
of Sir2K protein in mammalian cells
To investigate the tissue distribution of Sir2K protein in
embryos, we developed a polyclonal antibody against the car-
boxy-terminal region of mouse Sir2K. The raised anti-Sir2K
antibody could be used in Western blotting (Fig. 2A,B) and
also in immunostaining (Fig. 2C). In accordance with previ-
ously reported results [15,16], a band at approximately 120
kDa was detected in COS7 cell lysates transfected with
Sir2K cDNA (Fig. 2A, left lane). The band was speci¢cally
abolished in the presence of an antigenic peptide (Fig. 2B, left
lane). Immuno£uorescent microscopic examination of COS7
cells transfected with Sir2K cDNA showed speci¢c immuno-
Fig. 1. Expression levels of Sir2K mRNA in various mouse tissues
and embryos. A: Expression of Sir2K mRNA in various mouse tis-
sues. RNAs from mouse tissues were subjected to RT-PCR using
speci¢c primers for Sir2K. NC, negative control; PC, positive con-
trol. B: Quantitative analysis of Sir2K mRNA in mouse tissues. Ex-
pression levels of Sir2K mRNA were assessed by quantitative RT-
PCR using a Prism 7700 sequence detector. Sir2K mRNA levels
were normalized to GAPDH mRNA levels. Data are presented as
the meanTS.E.M. (n=3). C: Northern blot analysis of Sir2K during
embryogenesis. Expression levels of Sir2K mRNA in the mouse em-
bryo at the indicated di¡erent stages. A mouse embryo blot (20 Wg
of total RNA/lane) was probed with a 32P-labeled cRNA fragment
of Sir2K (upper panel, numbers indicating embryonic days). Levels
of 28S and 18S ribosomal RNA were used as internal standards
(lower panel). D: The content of Sir2K mRNA of each embryonic
stage was normalized using each content of 28S ribosomal RNA
and represented as a percentage of the value on E4.5.
Fig. 2. Western blot and immunohistochemical detection of Sir2K in
COS7 cells. A: Anti-Sir2K antibody recognizes 120-kDa Sir2K pro-
tein in COS7 cells transfected with Sir2K cDNA (left lane). Posi-
tions of molecular mass markers are indicated on the left side of
the panel. B: The addition of an excess of antigenic peptide abol-
ished the signal. C: Immunostaining of COS7 cells transfected with
Sir2K cDNA. Transiently transfected cells were stained with anti-
Sir2K antibody (a^c). Anti-Sir2K antibody preabsorbed with antigen-
ic peptide showed speci¢city of the antibody (d^f). Hoechst staining
of the same ¢eld is shown in panels b and e to indicate nuclei of
the cells. A merged image shows the nuclear localization of Sir2K
protein (c). The scale bar represents 50 Wm.
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staining of Sir2K (Fig. 2C). The speci¢city of the staining was
also validated by the results of an absorption experiment us-
ing an excess of an antigenic peptide (Fig. 2C, panel d).
Sir2K localized in the nuclei of transfected cells, and the
nuclear localization of Sir2K is consistent with results of pre-
vious studies [15,16].
3.5. Immunolocalization of Sir2K protein in the mouse embryo
Abundant expression of Sir2K mRNA in middle and late
developmental stages suggests the involvement of Sir2K in
organogenesis. Therefore, we investigated the tissue distribu-
tion and developmental change of Sir2K protein in mouse
fetuses from E10.5 to E16.5. To compare each section with
others we carefully standardized our experimental conditions.
Although Sir2K protein was expressed ubiquitously in em-
bryos at all stages examined, we found speci¢c and prominent
immunoreactivity in the heart, brain, spinal neural tube, and
dorsal root ganglion at E10.5^E13.5. Histological abnormal-
ities in the pancreas and lung in Sir2K-null mice had been
found in a previous study [18], but these organs did not
show predominant expression of Sir2K protein. In the embry-
onic heart, the most intense immunostaining was seen from
E10.5 to E12.5 (Fig. 3A,B). The expression of Sir2K in the
heart of E13.5 embryos had slightly decreased (Fig. 3C), and
the immunoreactivity had clearly decreased on E14.5 and
E16.5 (Fig. 3C^E). In the developing brain, strong staining
for Sir2K was detected at the wall of the telencephalic vesicle
on E10.5 (Fig. 3A). As brain formation proceeded, strong
immunoreactivity was evident in the diencephalon, hindbrain,
spinal cord, and dorsal root ganglia of E12.5 and E13.5 em-
bryos (Fig. 3B,C). Immunoreactivity of Sir2K in the central
nervous system was slightly decreased on E14.5 (Fig. 3D). We
found that the neural expression level of Sir2K on E16.5 was
reduced compared with those on E10.5^E15.5 (Fig. 3F).
Hey2, a Hairy-related basic helix-loop-helix (bHLH) tran-
scription factor, has recently been reported to bind to Sir2K
[20]. Hey2 is thought to contribute to ventricular development
of the embryo. Sir2K may interact with Hey2 and regulate
ventricular formation. We compared the expression pattern
of Sir2K in the heart ventricles with that in the atrium
(Fig. 4). In the E12.5 heart, Sir2K was expressed strongly in
the atrium (Fig. 4D) and the ventricle (Fig. 4G) at almost the
same levels. Strong immunostaining of nuclei was observed in
cells in the atrium and ventricle. In the E14.5 embryo, the
expression levels of Sir2K in both chambers (Fig. 4E,H)
were reduced to comparable extents, and intensity of nuclear
staining was also reduced. The E16.5 heart showed weak ex-
pression of Sir2K similar to the levels of expression in other
organs (Fig. 4F,I). Myocytes in the atrium and ventricle
showed identical time courses of Sir2K expression.
3.6. Expression levels of Sir2K in the developing heart
To examine the expression levels of Sir2K mRNA and pro-
tein in developing hearts, total RNA and tissue lysates were
Fig. 3. Immunohistochemical detection of Sir2K protein in mouse embryos from E10.5 to E16.5. Sections of ¢xed whole embryos (E10.5^16.5)
of ddY mice were stained with anti-Sir2K antibody. Sir2K protein was prominently expressed in the embryonic heart and brain, and the expres-
sion levels gradually decreased. Arrowheads indicate embryonic hearts. tv, telencephalic vesicle; di, diencephalon; hi, hindbrain; sc, spinal
cord; drg, dorsal root ganglion. The scale bar represents 2 mm.
Fig. 4. Expression of Sir2K protein in developing hearts on E12.5
(A), E14.5 (B) and E16.5 (C). Whole embryonic sections (5 Wm)
were immunostained with anti-Sir2K antibody. Middle panels (D^F)
and right panels (G^I) show a higher magni¢cation of the atrium
and ventricle of the heart, respectively. Prominent expression of
Sir2K was found in the atrium and ventricle in E12.5 embryos, and
the expression levels gradually decreased. a, atrium; v, ventricle.
The scale bar represents 1 mm in panels A^C and 100 Wm in panels
D^I.
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prepared from embryonic hearts on E12.5, E14.5 and E16.5,
from hearts on postnatal day 1 (P1), and from hearts of 10-
week-old (10W) and 27-month-old (27M) mice. Real-time
quantitative RT-PCR analysis was used for precise measure-
ment of the Sir2K mRNA expression levels (Fig. 5A). Sir2K
mRNA was detected not only in the embryonic and newborn
hearts but also in the young adult and senile hearts. The E12.5
heart expressed the highest level of Sir2K mRNA, which is
consistent with our immunohistochemical observation. The
content of Sir2K mRNA on E14.5 was about 40% of that
on E12.5, indicating that a rapid decrease in Sir2K mRNA
had occurred between E12.5 and E14.5. The expression level
of Sir2K mRNA on E16.5 was 21% of that on E12.5 and
almost the same as that on P1. After birth, the level remained
constant up to 27 months of age. Expression of Sir2K protein
in hearts of developmental stages are shown in Fig. 5B. In
accordance with Sir2K mRNA levels, the amounts of 120-kDa
bands decreased gradually with development of the heart. The
protein content was further reduced after birth. These data
are consistent with results of Northern blot analysis (Fig. 2)
and immunohistochemical analysis of embryos (Figs. 4 and 5).
4. Discussion
Northern blot analysis of embryos from E4.5 to E18.5
showed that there was abundant expression of Sir2K mRNA
in these embryonic stages. The highest level of expression was
detected in embryos as early as E4.5. Since two-cell-stage em-
bryos have been shown to express Sir2K [18], Sir2K may be
continuously expressed throughout embryogenesis and may
play a role in early embryonic development. We also found
that Sir2K mRNA was still expressed in the middle and late
embryonic stages. In E10.5^E14.5 embryos, prominent expres-
sion of Sir2K was detected in the heart and nervous system.
Immunohistochemical analysis also showed down-regulation
of Sir2K expression after E13.5 in the embryonic heart and
after E15.5 in the nervous system. The results of a quantita-
tive RT-PCR experiment also showed a rapid decline in Sir2K
mRNA content in the heart between E12.5 and E14.5. Ex-
pression pro¢les of Sir2K in both the heart and brain suggest
that Sir2K plays a critical role in the formation of these or-
gans. The results of our study are consistent with those of
previous studies demonstrating developmental defects in the
brain [18,19] and heart [19] in Sir2K-null embryos.
The heart is the ¢rst organ to di¡erentiate and function for
delivery of nutrients in the embryo. Development of the heart
starts around E7.5, and beating of the heart, which is just a
simple tube, is observed at the end of E8. A four-chambered
heart appears by about E12 [21]. Sir2K is strongly expressed
on E10.5^12.5, the period of development in which the cham-
bers of the heart are formed. These ¢ndings led us to speculate
that strong expression of Sir2K may function as one of the
regulators of cardiac morphogenesis. Since cardiomyocytes
continue to proliferate and enlarge until the postnatal period,
the signi¢cance of a high level of expression of Sir2K may be
secondary to the proliferation of undi¡erentiated cells. The
brain also begins to di¡erentiate at early stages of embryo-
genesis. The earliest appearance of what can be considered
brain tissues is distinguishable on E7.5. By E12, the dienceph-
alon di¡erentiates into the thalamus, epithalamus and hypo-
thalamus, and the hindbrain di¡erentiates into the cerebellum
and medulla oblongata [21]. Di¡erentiation of the neural tis-
sues continues after birth. The diencephalon and hindbrain
exhibited intense expression of Sir2K on E12.5 (Fig. 3B).
The ¢rst notable reduction in the level of expression of neural
Sir2K occurred between E13.5 and E14.5, which is similar to
cardiac Sir2K (Fig. 3C,D). There may be a second decrease in
Sir2K expression level in the brain between E15.5 and E16.5
(Fig. 3E,F). The slower decline in Sir2K expression level in the
brain compared to that in the heart may re£ect developmental
di¡erences between the two organs. Detailed examination of
temporal and spatial expression patterns of Sir2K in the brain
may be necessary to understand the function of Sir2K in brain
formation.
Many transcription factors have been delineated as regula-
tors of cardiogenesis [22,23] and neurogenesis [24]. Hes1 and
Hey2, which are classi¢ed as bHLH transcription factors,
have been reported to bind to Sir2K [20]. Sir2K enhanced
transcriptional repression activities of Hes1 and Hey2. Hes1
is expressed in neural precursor cells, and its expression level
decreases as neurogenesis proceeds [25]. It prevents premature
neural di¡erentiation, and down-regulation of Hes1 is re-
quired for precursor cells to enter the di¡erentiation process.
Comparable expression patterns of Hes1 and Sir2K suggest
that the two proteins are coordinated in the process of neural
development. Sir2K may function in the inhibition of di¡er-
entiation and/or proliferation of undi¡erentiated cells. Hey2,
which is detectable on E7.5 in the primitive heart tube, exhib-
its ventricle-speci¢c expression and is presumed to regulate
morphogenesis of the ventricle [26,27]. Since we detected al-
Fig. 5. Sir2K mRNA and protein expression levels in mouse hearts
at di¡erent developmental stages. A: Sir2K mRNA expression levels
in the embryonic heart (E12.5, E14.5, E16.5), neonatal heart from
day 1 (P1), and adult heart from 10 weeks and 27 months were ex-
amined. Real-time quantitative RT-PCR was performed, and Sir2K
mRNA levels were normalized to GAPDH mRNA levels. Values
are averagesT S.E.M. (n=4). *P6 0.05, signi¢cantly di¡erent from
10 W. B: Developmental changes in the amount of Sir2K protein in
the mouse heart were determined by Western blot analysis. Heart
lysates were prepared at the indicated time points. Each lane con-
tained 100 Wg of protein. The amount of protein loaded on the gels
was determined by reprobing the same membrane with an anti-
GAPDH antibody. Cell lysates from COS7 cells that had been
transfected with Sir2K cDNA were used as controls.
FEBS 27972 19-12-03 Cyaan Magenta Geel Zwart
J. Sakamoto et al./FEBS Letters 556 (2004) 281^286 285
most the same levels of immunoreactivity of Sir2K in the
ventricle and atrium (Fig. 4D,G), transcriptional factors other
than Hey2 may be involved in the development of the atrium.
Although Hey2 and Hes1 are attractive candidates for tran-
scription factors that orchestrate the heart and brain forma-
tion with Sir2K, further studies are required to identify target
proteins of Sir2K. Recently, Sir2K was reported to interact
with MyoD, a bHLH transcription factor, and to inhibit dif-
ferentiation of muscle precursor cells to mature muscle cells
[28]. Thus, Sir2K may function as an inhibitor of di¡erentia-
tion.
The anti-apoptotic property of Sir2K [15,16] may be anoth-
er regulatory mechanism involved in organ formation. In ad-
dition to cell proliferation, apoptosis is also a component of
cardiogenesis [29,30] and neurogenesis [31,32]. Interestingly,
TUNEL-positive cells have been detected in the mouse car-
diac ventricle from E13 [33], when a decrease in Sir2K expres-
sion level was observed. Thus, there is a possibility that Sir2K
inhibits apoptosis in the developing heart, though an anti-ap-
optotic function of Sir2K has been demonstrated only for ap-
optosis induced by p53 and the role of p53 in cardiogenesis is
still unknown.
A quantitative RT-PCR experiment and Western blot anal-
ysis detected Sir2K expression in adult hearts. Although Sir2K
is thought to contribute to embryogenesis, it may play anoth-
er role in adulthood.
The results of this study suggest that Sir2K is involved in
embryogenesis, particularly in the development of the heart
and brain. Functions of Sir2K appear worth investigating fur-
ther for a better understanding of mammalian organogenesis.
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